Literature DB >> 19368692

H-cadherin expression reduces invasion of malignant melanoma.

Silke Kuphal1, Adam C Martyn, Julie Pedley, Lisa M Crowther, Vanessa F Bonazzi, Peter G Parsons, Anja K Bosserhoff, Nicholas K Hayward, Glen M Boyle.   

Abstract

Melanocytic behavior, survival, and proliferation are regulated through a complex system of cell-cell adhesion molecules. Pathologic changes leading to development of malignant melanoma, upset the delicate homeostatic balance between melanocytes and keratinocytes and can lead to altered expression of cell-cell adhesion and cell-cell communication molecules. Malignant transformation of melanocytes frequently coincides with loss of E-cadherin expression. We now show loss of another member of the superfamily of classical cadherins, H-cadherin (CDH13), which may be involved in the development of malignant melanoma. The provided data show that H-cadherin expression is lost in nearly 80% of the analyzed melanoma cell lines. Knockdown of H-cadherin using siRNA increases invasive capacity in melanocytes. Functional assays show that the re-expression of H-cadherin decreases migration and invasion capacity, as well as anchorage-independent growth in comparison to control melanoma cells. Furthermore, melanoma cells, which re-express H-cadherin via stable transfection show a reduction in rate of tumor growth in a nu/nu mouse tumor model in comparison to the parental control transfected cell lines. Our study presents for the first time the down-regulation of H-cadherin in malignant melanomas and its possible functional relevance in maintenance healthy skin architecture.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19368692     DOI: 10.1111/j.1755-148X.2009.00568.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  23 in total

1.  Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.

Authors:  Mark J Schliekelman; Don L Gibbons; Vitor M Faca; Chad J Creighton; Zain H Rizvi; Qing Zhang; Chee-Hong Wong; Hong Wang; Christin Ungewiss; Young-Ho Ahn; Dong-Hoon Shin; Jonathan M Kurie; Samir M Hanash
Journal:  Cancer Res       Date:  2011-10-10       Impact factor: 12.701

2.  DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation.

Authors:  Meina Wang; Kaili Long; Enjie Li; Lulu Li; Binghua Li; Shusheng Ci; Lingfeng He; Feiyan Pan; Zhigang Hu; Zhigang Guo
Journal:  Oncogene       Date:  2020-07-08       Impact factor: 9.867

3.  Increased DNA methyltransferase activity and DNA methylation following Epidermal Growth Factor stimulation in ovarian cancer cells.

Authors:  Sabrina L Samudio-Ruiz; Laurie G Hudson
Journal:  Epigenetics       Date:  2012-03       Impact factor: 4.528

4.  Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue.

Authors:  Erika M Wolff; Yoshitomo Chihara; Fei Pan; Daniel J Weisenberger; Kimberly D Siegmund; Kokichi Sugano; Kiyotaka Kawashima; Peter W Laird; Peter A Jones; Gangning Liang
Journal:  Cancer Res       Date:  2010-09-14       Impact factor: 12.701

5.  Supervised machine learning and logistic regression identifies novel epistatic risk factors with PTPN22 for rheumatoid arthritis.

Authors:  F B S Briggs; P P Ramsay; E Madden; J M Norris; V M Holers; T R Mikuls; T Sokka; M F Seldin; P K Gregersen; L A Criswell; L F Barcellos
Journal:  Genes Immun       Date:  2010-01-21       Impact factor: 2.676

6.  T-Cadherin Expression in Melanoma Cells Stimulates Stromal Cell Recruitment and Invasion by Regulating the Expression of Chemokines, Integrins and Adhesion Molecules.

Authors:  Kseniya A Rubina; Ekaterina I Surkova; Ekaterina V Semina; Veronika Y Sysoeva; Natalia I Kalinina; Alexei A Poliakov; Helena M Treshalina; Vsevolod A Tkachuk
Journal:  Cancers (Basel)       Date:  2015-07-21       Impact factor: 6.639

7.  Clinical relevance of CDH1 and CDH13 DNA-methylation in serum of cervical cancer patients.

Authors:  Abida Abudukadeer; Rania Bakry; Georg Goebel; Irene Mutz-Dehbalaie; Andreas Widschwendter; Günther K Bonn; Heidi Fiegl
Journal:  Int J Mol Sci       Date:  2012-07-05       Impact factor: 6.208

8.  Effects of T-cadherin expression on B16F10 melanoma cells.

Authors:  Xin-Suo Duan; Jie Lu; Zhi-Hua Ge; En-Hong Xing; Hai-Tao Lu; Li-Xin Sun
Journal:  Oncol Lett       Date:  2013-01-30       Impact factor: 2.967

9.  The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.

Authors:  Nina Fenouille; Mélanie Tichet; Maeva Dufies; Anaïs Pottier; Ariane Mogha; Julia K Soo; Stéphane Rocchi; Aude Mallavialle; Marie-Dominique Galibert; Amir Khammari; Jean-Philippe Lacour; Robert Ballotti; Marcel Deckert; Sophie Tartare-Deckert
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

10.  Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.

Authors:  Juan F Santibanez
Journal:  ISRN Dermatol       Date:  2013-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.